Merck's latest campaign for its oncology blockbuster Keytruda emphasizes the passions and talents of people living with cancer. (Credit: Merck)

July 24, 2023 03:04 PM EDT

Marketing

Merck evolves Keytruda ad campaign, building on patient insights and highlighting 16 approvals

Beth Snyder Bulik

Senior Editor

Cancer patients don’t want to be defined by their disease. Merck’s latest campaign for its immuno-oncology blockbuster Keytruda homes in on that insight by highlighting …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Merck evolves Keytruda ad campaign, building on patient insights and highlighting 16 approvals

Beth Snyder Bulik

Senior Editor

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA approves first drug to treat ultra-rare lipid storage disease

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Mer­ck evolves Keytru­da ad cam­paign, build­ing on pa­tient in­sights and high­light­ing 16 ap­provals

Senior Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Merck evolves Keytruda ad campaign, building on patient insights and highlighting 16 approvals